ATE458830T1 - Verfahren zur untersuchung einer zelle - Google Patents

Verfahren zur untersuchung einer zelle

Info

Publication number
ATE458830T1
ATE458830T1 AT04714457T AT04714457T ATE458830T1 AT E458830 T1 ATE458830 T1 AT E458830T1 AT 04714457 T AT04714457 T AT 04714457T AT 04714457 T AT04714457 T AT 04714457T AT E458830 T1 ATE458830 T1 AT E458830T1
Authority
AT
Austria
Prior art keywords
cancer
cell
enabled
tissue
carrying
Prior art date
Application number
AT04714457T
Other languages
English (en)
Inventor
Toshiyuki Sakai
Hideki Ishihara
Original Assignee
Sysmex Corp
Toshiyuki Sakai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp, Toshiyuki Sakai filed Critical Sysmex Corp
Application granted granted Critical
Publication of ATE458830T1 publication Critical patent/ATE458830T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/44—Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04714457T 2003-02-26 2004-02-25 Verfahren zur untersuchung einer zelle ATE458830T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003048653 2003-02-26
PCT/JP2004/002164 WO2004076686A1 (ja) 2003-02-26 2004-02-25 細胞の検査方法

Publications (1)

Publication Number Publication Date
ATE458830T1 true ATE458830T1 (de) 2010-03-15

Family

ID=32923298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04714457T ATE458830T1 (de) 2003-02-26 2004-02-25 Verfahren zur untersuchung einer zelle

Country Status (6)

Country Link
US (1) US7501257B2 (de)
EP (1) EP1600513B1 (de)
JP (1) JP4317188B2 (de)
AT (1) ATE458830T1 (de)
DE (1) DE602004025676D1 (de)
WO (1) WO2004076686A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005116241A1 (ja) * 2004-05-31 2005-12-08 Sysmex Corporation 哺乳動物細胞の性質判定方法及びこれを用いた癌の診断方法
US7957910B2 (en) * 2005-01-31 2011-06-07 Sysmex Corporation Method for predicting effectiveness of chemotherapy
JP4944446B2 (ja) * 2005-01-31 2012-05-30 シスメックス株式会社 抗がん剤治療の有効性予測方法
US7682785B2 (en) 2005-06-30 2010-03-23 Sysmex Corporation Method for predicting effectiveness of chemotherapy using anticancer agent
JP5046574B2 (ja) * 2005-06-30 2012-10-10 シスメックス株式会社 抗がん剤治療の有効性予測方法
ATE400815T1 (de) 2005-08-01 2008-07-15 Sysmex Corp Verfahren zur beurteilung der beschaffenheit maligner tumore
JP4766969B2 (ja) * 2005-09-14 2011-09-07 シスメックス株式会社 組織性質判定装置
JP2007259846A (ja) 2006-02-28 2007-10-11 Sysmex Corp 悪性腫瘍の性質の判定方法
JP5408839B2 (ja) * 2006-10-20 2014-02-05 オリンパス株式会社 細胞周期解析方法
JP5111902B2 (ja) * 2007-03-14 2013-01-09 シスメックス株式会社 癌の診断支援装置
JP2009089672A (ja) * 2007-10-10 2009-04-30 Sysmex Corp がんの再発リスクの判定方法
JP2010057486A (ja) * 2008-09-02 2010-03-18 Sysmex Corp 化学療法に対するがん患者の応答の予測方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997004316A1 (en) * 1995-07-20 1997-02-06 Paracelsian, Inc. Determination of the presence of abnormal cellular proliferation through the detection of one or more cyclin dependent kinases
US5672508A (en) * 1996-01-23 1997-09-30 Mitotix, Inc. Inhibitors of cell-cycle progression, and uses related thereto
US6048693A (en) * 1996-10-16 2000-04-11 Bittech, Inc. Phenotypic assays of cyclin/cyclin-dependent kinase function
US5914249A (en) * 1997-12-05 1999-06-22 Incyte Pharmaceuticals, Inc. Cell-cycle phosphoproteins
CA2321467A1 (en) * 1998-02-18 1999-08-26 Theryte Limited Treating cancer
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US20030064426A1 (en) * 2001-02-01 2003-04-03 Jason Poole Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
JP4036655B2 (ja) 2001-02-14 2008-01-23 シスメックス株式会社 細胞周期調節因子の活性の測定法と該測定法に使用される試薬
ATE378400T1 (de) 2001-02-14 2007-11-15 Sysmex Corp Verfahren zur bestimmung der aktivität des zellzyklus-regulationsfaktors und verfahren zur diagnose von krebs unter verwendung desselben
EP1576173A4 (de) * 2002-07-12 2007-02-28 Rigel Pharmaceuticals Inc Modulatoren der zellproliferation

Also Published As

Publication number Publication date
EP1600513A1 (de) 2005-11-30
JPWO2004076686A1 (ja) 2006-06-08
EP1600513B1 (de) 2010-02-24
US20070031813A1 (en) 2007-02-08
WO2004076686A1 (ja) 2004-09-10
US7501257B2 (en) 2009-03-10
DE602004025676D1 (de) 2010-04-08
EP1600513A4 (de) 2007-09-12
JP4317188B2 (ja) 2009-08-19

Similar Documents

Publication Publication Date Title
DE602004025676D1 (de) Verfahren zur untersuchung einer zelle
Agrawal et al. New developments in tools for periodontal diagnosis
ES2531368T3 (es) Métodos y kits para diagnosticar tumorigenicidad y determinar resistencia a los efectos antineoplásicos de la terapia antiestrógeno
WO2008015599A3 (en) A method of in vivio detection and/or diagnosis of cancer using fluorescence based dna image cytometry
BRPI0412725B8 (pt) marcadores para detecção de câncer gástrico
WO2015071876A3 (en) Use of microrna markers for diagnosis of thyroid tumors and a diagnostic panel containing such markers.
EP1215495A3 (de) Verfahren zur Erhöhung der klinischen Spezifität bei der Detektion von Tumoren und ihren Vorstufen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
AU2012246764B2 (en) A Device and Method for Detecting a Harmonic Response Characteristic of Secondary Dental Caries Diagnosis
Sandor et al. Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscope for intraoperative margin assessment-POLARHIS study
WO2011133770A3 (en) Salivary protein markers for detection of breast cancer
Chen et al. Validation of micro‐CT against the section method regarding the assessment of marginal leakage of sealants
WO2005098433A3 (en) Diagnostic assays for alzheimer’s disease
DE602004006396D1 (de) Analyse einer zusammenstellung mit beobachtung
Maturo et al. Quantitative distinction of unique vocal fold subepithelial architectures using optical coherence tomography
Włodarczyk et al. The application of 24-hour pharyngeal pH-monitoring and Reflux Finding Score and Reflux Symptom Index questionnaires in the diagnostics of laryngopharyngeal reflux
Wheller et al. Noninvasive methods for the assessment of photoageing
Badea et al. Acoustic Radiation Force Impulse quantitative elastography: a new noninvasive technique for the evaluation of parotid glands. A preliminary study in controls and in patients with irradiated nasopharyngeal carcinoma.
ES2570609T3 (es) Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal
Torlakovic How to validate predictive immunohistochemistry testing in pathology?
WO2006110768A3 (en) System, method and software arrangement for analyzing and correlating molecular profiles associated with anatomical structures
CN215019200U (zh) 一种能测量肿瘤距脏器切缘距离的仪器
WO2022241292A3 (en) Use of markers in the diagnosis and treatment of parkinson's disease
Bento Quantitative analysis of the mandible for sex estimation
Miteva et al. Ex vivo dermatoscopy of scalp specimens and slides
EP1988164A4 (de) Verfahren zum testen der empfindlichkeit eines soliden tumors gegenüber tyrosinkinase-inhibitor sowie testkit dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties